BeyondSpring (BYSI) Debt Ratio (2015 - 2021)

BeyondSpring (BYSI) posted Debt Ratio of 0.02 for Q4 2021, up 21.8% sequentially from 0.02 in Q3 2021, and up 3.79% YoY from 0.02 in Q4 2020.

BeyondSpring (BYSI) Debt Ratio (2015 - 2021) Analysis & Trends

BeyondSpring has reported Debt Ratio for 6 years, with the latest figure at 0.02 in Q4 2021.

Quarterly Debt Ratio rose 3.79% year-over-year to 0.02 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 0.02 (up 3.79% YoY) and the FY2021 annual result came in at 0.02, up 3.79% from the prior year.
Debt Ratio climbed to 0.02 in Q4 2021 per BYSI's latest filing, from 0.02 in the prior quarter.
Over five years, Debt Ratio peaked at 0.71 in Q2 2019 and troughed at 0.0 in Q2 2017.
A 4-year average of 0.1 and a median of 0.03 in 2021 frame the typical range for Debt Ratio.
The widest YoY moves for Debt Ratio: up 30.58% in 2020, down 93.66% in 2020.
Over 4 years, Debt Ratio stood at 0.0 in 2017, then jumped by 71533.91% to 0.03 in 2019, then slumped by 43.69% to 0.02 in 2020, then rose by 3.79% to 0.02 in 2021.
According to Business Quant data, Debt Ratio over the past three periods registered 0.02, 0.02, and 0.03 for Q4 2021, Q3 2021, and Q2 2021 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.05
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.03
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.47
10	BeyondSpring	29.85 Mn	29.85 Mn	-	-

Download Data